in Newswire October 9, 2019

Allergan Hit with More Proposed Class Action Litigation Over Biocell Implant Cancer Risk

by Corrado Rizzi

Last Updated on October 9, 2019

Doe et al. v. Allergan, Inc. et al.

Filed: October 2, 2019 § 7:19-cv-09151

Allergan faces more potential class action litigation over its recalled Biocell textured breast implants' connection to BIA-ALCL, a cancer of the immune system.



New York

Last Updated on October 9, 2019 — 3:10 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.